Alborz Investment Group Company Public Joint Stock, located in Tehran, was founded under the name "Yekdel" on December 24th, 1966. It was initially registered as a public company and later became a private joint stock company on October 20th, 1971. In July 25th, 1974, it was converted back to a public company and its name was changed to Alborz Investigation Co. The main activity of Alborz Investment Group is investing and contributing in firms, production, commercial and construction companies, as well as trading securities and engaging in any legal commercial activity related to the company's scope. Alborz Investment Group was established in 1966 with a focus on the production and distribution of medicines, detergents, and foodstuff. Over the years, the company has become a leading and innovative group. Some of its important companies include Tolid Darou, Iran Darou, KBC, Toli Pers, Keyvan, and Pakhsh Alborz. These companies are involved in the manufacturing of pharmaceutical, cosmetic, and health products, as well as confectionery and distribution of health products. In recent years, Alborz Investment Group has shifted its focus to the pharmaceutical industry and has developed a production chain consisting of raw material production and product distribution. The company is listed on the Tehran Stock Exchange and has over 18,000 real and legal shareholders, 13 reputable subsidiary companies listed on the Stock Exchange, and more than 3,200 skilled and experienced personnel. Alborz Investment Group plays a significant role in the production and supply of pharmaceuticals in Iran.
Headquarters
Arzhantin Square, Ahmed Qasir St, No.11, Fifth Street
Tehran; Tehran;
Postal Code: 1513718111
Contact Details: Purchase the Alborz Investment Group Company Public Joint Stock report to view the information.
Website: http://www.alborzinvest.ir
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service